Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Cellectar Biosciences, Inc. (CLRB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 4.12 shares as of 2019-03-31, per its 10-Q filed 2019-05-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2019-05-06
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 4.12 shares.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 21.34 shares.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 21.00 shares.
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.67 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2019-03-31 | 4.12 shares 10-Q · filed 2019-05-06 |
| 2018-09-30 | 21.34 shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 21.00 shares 10-Q · filed 2018-08-10 |
| 2018-03-31 | 6.67 shares 10-Q · filed 2018-05-11 |
| 2017-09-30 | 246.73K shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 146.36K shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 104.11K shares 10-Q · filed 2017-05-11 |
| 2016-12-31 | 74.01K shares 10-K · filed 2017-03-15 |
| 2016-09-30 | 52.74K shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 31.30K shares 10-Q · filed 2016-08-11 |
| 2016-03-31 | 23.43K shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 23.68K shares 10-K/A · filed 2016-10-20 |
| 2015-09-30 | 253.56K shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 315.20K shares 10-Q · filed 2015-08-12 |
| 2015-03-31 | 365.87K shares 10-Q · filed 2015-05-20 |
| 2014-12-31 | 333.91K shares 10-K · filed 2015-05-20 |
| 2014-09-30 | 278.05K shares 10-Q · filed 2015-05-20 |
| 2014-06-30 | 264.75K shares 10-Q · filed 2014-08-04 |
| 2014-03-31 | 4.93M shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | 4.91M shares 10-K · filed 2014-03-19 |
| 2013-09-30 | 3.67M shares 10-Q · filed 2013-11-13 |
| 2013-06-30 | 3.42M shares 10-Q · filed 2013-08-12 |
| 2013-03-31 | 2.88M shares 10-Q · filed 2013-05-15 |
| 2012-12-31 | 2.35M shares 10-K · filed 2013-03-28 |
| 2012-09-30 | 1.95M shares 10-Q · filed 2012-11-06 |
| 2012-06-30 | 1.56M shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |